| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2003 | WO2002080901A3 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
| 01/09/2003 | WO2002078617A3 Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| 01/09/2003 | WO2002076397A3 Telomerase inhibitors and methods of their use |
| 01/09/2003 | WO2002076376A3 A stable pharmaceutical composition of pravastatin |
| 01/09/2003 | WO2002072536A8 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 01/09/2003 | WO2002072084A8 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
| 01/09/2003 | WO2002071874A3 Composition improving age-related physiological deficits and increasing longevity |
| 01/09/2003 | WO2002069994A3 Combined use of derivatives of glp-1 analogs and ppar ligands |
| 01/09/2003 | WO2002069940A3 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 01/09/2003 | WO2002069887A3 Virucidal compositions |
| 01/09/2003 | WO2002064594A3 6-substituted pyrido-pyrimidines |
| 01/09/2003 | WO2002064110A3 Carotenoid-loaded liposomes |
| 01/09/2003 | WO2002063014A3 Human tyrosine-specific protein phosphatase |
| 01/09/2003 | WO2002062777A9 Amino ceramide-like compounds and therapeutic methods of use |
| 01/09/2003 | WO2002060486A3 Controlled release microsphere system for administration of drug to the eye |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002059102A3 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 01/09/2003 | WO2002057231A3 Benz(g) indoles and their use as spla2 inhibitors |
| 01/09/2003 | WO2002051401A3 Controlled release formulations of divalproex sodium |
| 01/09/2003 | WO2002049622A3 Transdermal system containing a novel high potency progestagen |
| 01/09/2003 | WO2002047686A8 Substituted-4-quinolones |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002043664A3 Reducing cellular damage in the human body |
| 01/09/2003 | WO2002038127A3 Particle formation methods and their products |
| 01/09/2003 | WO2002034236A3 Lipid formulations for target delivery |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002032943A3 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 01/09/2003 | WO2002015845A3 Anti-hypercholesterolemic drug combination |
| 01/09/2003 | WO2002013855A3 Vaccines containing ribavirin and methods of use thereof |
| 01/09/2003 | WO2002009762A3 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 01/09/2003 | WO2002009716A3 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 01/09/2003 | WO2002007669A3 Phospholipid derivatives of valproic acid and mixtures thereof |
| 01/09/2003 | WO2002003970A2 Matrix controlled transdermal system for stabile derivatives of ace inhibitors |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001098351A3 G-protein coupled receptors |
| 01/09/2003 | WO2001097793A3 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 01/09/2003 | WO2001093848A3 Starter kit for low dose oral contraceptives |
| 01/09/2003 | WO2001091740A3 Compositions containing naphthaquinone and an antiproliferative agent |
| 01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
| 01/09/2003 | WO2001070213A3 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide oxy amide or 8-hydroxy quinoline structure |
| 01/09/2003 | WO2001068637A3 Method for the preparation of tetrahydrobenzothiepines |
| 01/09/2003 | WO2001062297A9 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/09/2003 | WO2001062238A9 Ppar gamma agonists for the treatment of liver inflammatory disorders |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009042 Method for making hydroxy-25-ene-vitamin D compounds |
| 01/09/2003 | US20030009036 To produce polymers; cancer therapy |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030009032 For inhibiting the replication or infectivity of a virus; therapy |
| 01/09/2003 | US20030008926 Food-grade insecticidal formulation allowed for use in organic production which is effective in controlling insects, such as ants, aphids, mealy bugs, white flies, spider mites, leaf hoppers, cabbage loopers, leaf eating beetles and caterpillars |
| 01/09/2003 | US20030008925 Using benzhydrylsulphinyl compounds for the manufacture of medicaments having an awakening effect in situations of disorders in vigilance associated with a morphine treatment |
| 01/09/2003 | US20030008924 Providing cell which overexpresses a Bcl-2 family protein; gossypol compound; treating with cell with an effective amount of gossypol compound under conditions such that apoptosis in cell is modulated |
| 01/09/2003 | US20030008923 Administering combination comprising an mTOR inhibitor and an antineoplastic alkylating agent |
| 01/09/2003 | US20030008922 Multiple drug resistance reversal agent |
| 01/09/2003 | US20030008921 Orally or parenterally administrable combination preparation comprising in admixture L-carnitine and acetyl L-carnitine for therapy of disorder of sperm motility |
| 01/09/2003 | US20030008920 Methods for reducing atherosclerotic plaques |
| 01/09/2003 | US20030008919 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 01/09/2003 | US20030008917 For preparation of disinfectants, sterilizing formulations, antiseptics, preservatives, which are suitable for the sterilization and disinfection of surfaces and surgical instruments, and preservation of cosmetics, foods |
| 01/09/2003 | US20030008916 Mixing a compound which acts as a local anesthetic with physiological salt; placing formulation in a catheter; administering formulation into uterine cavity of woman with a catheter; pertubating the formulation into peritoneal cavity |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008914 Pharmaceutical formulations useful to treat inflammatory and immune disorders |
| 01/09/2003 | US20030008912 Methods for treating circadian rhythm phase disturbances |
| 01/09/2003 | US20030008911 Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| 01/09/2003 | US20030008910 Use of proteasome inhibitors to treat dry eye disorders |
| 01/09/2003 | US20030008909 For therapy of uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy; carcinomas and adenocarcinomas of endometrium, ovary, breast, colon, prostate, pituitary, meningioma and other hormone-dependent tumors |
| 01/09/2003 | US20030008908 Isoxazoline compounds having MIF antagonist activity |
| 01/09/2003 | US20030008907 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 01/09/2003 | US20030008906 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 01/09/2003 | US20030008905 Increasing the capacity of insulin providing cells in an animal by administering to animal a dose of at least one Dipeptidyl-peptidase (DP IV) enzyme activity effector |
| 01/09/2003 | US20030008904 For therapy of angina pectoris, atherosclerosis, hypertension and hyperlipidemia |
| 01/09/2003 | US20030008903 Administering to a human a therapeutically effective amount of optically pure R(+)isomer of lansoprazole, or a pharmaceutically acceptable salt for therapy of ulcers |
| 01/09/2003 | US20030008902 Paroxetine tablets & capsules |
| 01/09/2003 | US20030008901 For therapy of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008899 For use as medicine for antagonising the effects of excitatory amino acids upon the NMDA receptor complex |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008897 Using compounds such as N,N-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl amine hydrochloride for therapy of weight gain associated with treatment with certain drug therapy such as the use of tricyclic antidepressants |
| 01/09/2003 | US20030008896 Isoquinolinone derivatives |
| 01/09/2003 | US20030008894 Antimicrobial quinolones, their compositions and uses |
| 01/09/2003 | US20030008893 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation |
| 01/09/2003 | US20030008892 Pharmaceutical composition and method of modulating cholinergic function in a mammal |
| 01/09/2003 | US20030008890 For therapy of neurological and psychological disorders |
| 01/09/2003 | US20030008889 Aminoadamantane derivatives as therapeutic agents |
| 01/09/2003 | US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/09/2003 | US20030008887 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 01/09/2003 | US20030008886 For therapy of pain |
| 01/09/2003 | US20030008883 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/09/2003 | US20030008880 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| 01/09/2003 | US20030008879 For therapy of symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine; for therapy of anxiety |
| 01/09/2003 | US20030008877 CCR5 antagonists useful for treating AIDS |
| 01/09/2003 | US20030008876 Can mimic or block the effect of extracellular calcium on a cell surface calcium receptor; for use in therapy |
| 01/09/2003 | US20030008875 Use of regularly scheduled high dose intravenous methotrexate therapy, with interim administration of immunomodulatory agents, to treat multiple sclerosis and other diseases of the central nervous system |
| 01/09/2003 | US20030008874 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists |
| 01/09/2003 | US20030008873 For therapy of cancer |
| 01/09/2003 | US20030008872 2,3-Diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 01/09/2003 | US20030008871 Administering sulfonyl pyridazinone compounds for therapy and prophylaxis of tissue damage resulting from ischemia |
| 01/09/2003 | US20030008870 Prophylaxis of painful uterine cramps, dysmenorrhea, in women |
| 01/09/2003 | US20030008869 Combination of a PTPase inhibitor and a sulfonylurea agent |
| 01/09/2003 | US20030008868 Compounds useful as anti-inflammatory agents |
| 01/09/2003 | US20030008867 Compounds |